Thailand’s Chulalongkorn Uni to begin human trials of its mRNA vaccine in April

13 Sept 07:40 Key points summarised by AI

Chulalongkorn University's vaccine research centre will commence human trials for its mRNA vaccine candidate in April, initially with 72 volunteers to assess dosages.
A subsequent second stage, from June to September, will evaluate the vaccine's efficacy and safety on approximately 600 volunteers.
A significant advantage of this mRNA vaccine is its ability to be stored at 5oC, offering easier logistics compared to the -70oC requirement of the Pfizer vaccine.
If trials progress successfully, production could begin this year, with an aim to make the first million doses available within the year.

Six injured after car smashes into On Nut shopping mall

Yesterday 22:44 Key points summarised by AI

A 67-year-old woman drove her car through the glass frontage of a Bangkok shopping mall, injuring six people, including a six-year-old girl.
The driver claimed she accidentally pressed the accelerator instead of the brake after being startled, causing the vehicle to surge forward.
She apologized to the victims, promising insurance coverage and additional financial aid, while police continue to gather statements before filing charges.